A. Mehta

Case Report of a Pregnancy During Ipilimumab Therapy

Kevin B. Kim, D. Minor, A. Mehta, 2017, Journal of global oncology.

Placental site trophoblastic tumour--a case report.

A. Bahal, D. Gulati, M. P. Muttagikar, 2006, Indian Journal of Pathology and Microbiology.

Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas

Michael L. Wang, L. Gordon, D. Maloney, 2019, Blood.

Obinutuzumab (G)-atezolizumab (atezo)-lenalidomide (len) for the treatment of relapsed/refractory (R/R) follicular lymphoma (FL): Final analysis of a phase Ib/II trial.

I. Lossos, G. Salles, O. Casasnovas, 2021 .

Promising tolerability and efficacy results from dose-escalation in an ongoing phase Ib/II study of mosunetuzumab (M) with polatuzumab vedotin (Pola) in patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin’s lymphoma (B-NHL).

I. Lossos, Y. Oki, K. Dorritie, 2021 .

SGNTGT-001: A phase 1 study of SEA-TGT, an effector-function enhanced monoclonal antibody (mAb), in advanced malignancies (trial in progress).

D. Davar, G. Curigliano, S. Ansell, 2021 .